nodes	percent_of_prediction	percent_of_DWPC	metapath
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.0294	0.0302	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—GRN—amyotrophic lateral sclerosis	0.0287	0.0295	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.0273	0.028	CbGpPWpGaD
Levomethadyl Acetate—Tamoxifen—SIGMAR1—amyotrophic lateral sclerosis	0.0272	1	CrCbGaD
Levomethadyl Acetate—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.0252	0.0259	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.025	0.0256	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.023	0.0237	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.0222	0.0229	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.0205	0.0211	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.0203	0.0209	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.019	0.0195	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.019	0.0195	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.019	0.0195	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.0189	0.0195	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.0188	0.0193	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—FSH signaling pathway—BDNF—amyotrophic lateral sclerosis	0.0185	0.019	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.0183	0.0188	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.0173	0.0178	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.0167	0.0172	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.0167	0.0172	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide GPCRs—C5AR1—amyotrophic lateral sclerosis	0.0161	0.0166	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.0157	0.0162	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.0155	0.016	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.0155	0.016	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.0153	0.0157	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.0145	0.0149	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.0144	0.0148	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.0142	0.0146	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.0142	0.0146	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.014	0.0144	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.0139	0.0142	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.0133	0.0136	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.0128	0.0132	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.0128	0.0132	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.0127	0.013	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.0119	0.0122	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.0119	0.0122	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.0117	0.012	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.011	0.0113	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.0109	0.0112	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.0109	0.0112	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.0106	0.0109	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	0.00981	0.0101	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00977	0.01	CbGpPWpGaD
Levomethadyl Acetate—CHRNA3—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.00971	0.00998	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—IL4-mediated signaling events—CD40LG—amyotrophic lateral sclerosis	0.00917	0.00943	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00848	0.00872	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—C5AR1—amyotrophic lateral sclerosis	0.00758	0.0078	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	0.00752	0.00773	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Opioid Signalling—PLA2G4A—amyotrophic lateral sclerosis	0.00741	0.00762	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	0.00688	0.00707	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—C5AR1—amyotrophic lateral sclerosis	0.0064	0.00658	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	0.0064	0.00657	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00613	0.0063	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	0.00601	0.00618	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—ATF1—amyotrophic lateral sclerosis	0.00582	0.00598	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP9—amyotrophic lateral sclerosis	0.00554	0.00569	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—C5AR1—amyotrophic lateral sclerosis	0.00509	0.00523	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	0.0049	0.00504	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00437	0.00449	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00431	0.00443	CbGpPWpGaD
Levomethadyl Acetate—CHRNB4—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	0.00416	0.00427	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	0.00412	0.00424	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—C5AR1—amyotrophic lateral sclerosis	0.00387	0.00398	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.0038	0.0039	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00374	0.00385	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00335	0.00344	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00335	0.00344	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Peptide ligand-binding receptors—C3—amyotrophic lateral sclerosis	0.00331	0.0034	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	0.00312	0.00321	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00306	0.00315	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—TPK1—amyotrophic lateral sclerosis	0.00291	0.00299	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—VAPB—amyotrophic lateral sclerosis	0.00291	0.00299	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.00285	0.00293	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00285	0.00293	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—G alpha (i) signalling events—C3—amyotrophic lateral sclerosis	0.00279	0.00287	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00274	0.00282	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00271	0.00278	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00268	0.00275	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00266	0.00273	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00247	0.00254	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—DAO—amyotrophic lateral sclerosis	0.00242	0.00249	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—CASP3—amyotrophic lateral sclerosis	0.00233	0.0024	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00233	0.00239	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Class A/1 (Rhodopsin-like receptors)—C3—amyotrophic lateral sclerosis	0.00222	0.00228	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—C5AR1—amyotrophic lateral sclerosis	0.00219	0.00225	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—DAO—amyotrophic lateral sclerosis	0.0021	0.00216	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—VAPB—amyotrophic lateral sclerosis	0.0021	0.00216	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—TPK1—amyotrophic lateral sclerosis	0.0021	0.00216	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—C5AR1—amyotrophic lateral sclerosis	0.00199	0.00204	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	0.00198	0.00204	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—VAPA—amyotrophic lateral sclerosis	0.00192	0.00198	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00184	0.00189	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.00179	0.00184	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GSR—amyotrophic lateral sclerosis	0.00169	0.00174	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR ligand binding—C3—amyotrophic lateral sclerosis	0.00169	0.00174	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—FIG4—amyotrophic lateral sclerosis	0.00168	0.00173	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00159	0.00164	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PLB1—amyotrophic lateral sclerosis	0.00155	0.00159	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	0.00154	0.00159	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—DAO—amyotrophic lateral sclerosis	0.00152	0.00156	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Integrated Breast Cancer Pathway—TP53—amyotrophic lateral sclerosis	0.0015	0.00154	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GSR—amyotrophic lateral sclerosis	0.00147	0.00151	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—RTN4—amyotrophic lateral sclerosis	0.00146	0.0015	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00139	0.00143	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—VCP—amyotrophic lateral sclerosis	0.00138	0.00142	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PFN1—amyotrophic lateral sclerosis	0.00134	0.00138	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00128	0.00131	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	0.00127	0.0013	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.00126	0.00129	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—CHAT—amyotrophic lateral sclerosis	0.00121	0.00124	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—GFAP—amyotrophic lateral sclerosis	0.00119	0.00122	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—C5AR1—amyotrophic lateral sclerosis	0.00117	0.00121	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PLB1—amyotrophic lateral sclerosis	0.00115	0.00118	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GSR—amyotrophic lateral sclerosis	0.00106	0.00109	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—PLA2G4A—amyotrophic lateral sclerosis	0.000982	0.00101	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000978	0.001	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000978	0.001	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—GPCR downstream signaling—C3—amyotrophic lateral sclerosis	0.000956	0.000982	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000894	0.000919	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000873	0.000898	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	0.00087	0.000894	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling by GPCR—C3—amyotrophic lateral sclerosis	0.000868	0.000892	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000831	0.000854	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—SQSTM1—amyotrophic lateral sclerosis	0.000807	0.000829	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000781	0.000803	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ATF1—amyotrophic lateral sclerosis	0.000757	0.000778	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000748	0.000768	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CASP9—amyotrophic lateral sclerosis	0.000721	0.000741	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	0.000707	0.000727	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000687	0.000706	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000649	0.000667	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—ERBB4—amyotrophic lateral sclerosis	0.000617	0.000634	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000597	0.000613	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—PLA2G4A—amyotrophic lateral sclerosis	0.00058	0.000596	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—APOE—amyotrophic lateral sclerosis	0.000565	0.000581	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000536	0.000551	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—C3—amyotrophic lateral sclerosis	0.000513	0.000527	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	0.000494	0.000508	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—APOE—amyotrophic lateral sclerosis	0.000491	0.000505	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—APOE—amyotrophic lateral sclerosis	0.000477	0.000491	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000469	0.000482	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.000431	0.000443	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000406	0.000417	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—IGF1—amyotrophic lateral sclerosis	0.000394	0.000405	CbGpPWpGaD
Levomethadyl Acetate—CYP19A1—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000387	0.000398	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—APOE—amyotrophic lateral sclerosis	0.000355	0.000365	CbGpPWpGaD
Levomethadyl Acetate—CYP3A7—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000336	0.000346	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—CASP3—amyotrophic lateral sclerosis	0.000304	0.000312	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—MMP9—amyotrophic lateral sclerosis	0.000287	0.000295	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—VEGFA—amyotrophic lateral sclerosis	0.000258	0.000265	CbGpPWpGaD
Levomethadyl Acetate—CYP3A5—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000243	0.00025	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	0.000218	0.000224	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.0002	0.000206	CbGpPWpGaD
Levomethadyl Acetate—OPRM1—Signaling Pathways—TP53—amyotrophic lateral sclerosis	0.000195	0.0002	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	0.000165	0.00017	CbGpPWpGaD
Levomethadyl Acetate—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	0.000113	0.000116	CbGpPWpGaD
